A clinical trial to study the effectiveness of Chaturabhadravaleha on clinical features of Tamakaswasa in children

To study the effectiveness of Chaturabhadravaleha on clinical features of Tamakaswasa in children - An open label randomized controlled clinical trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053838

Enrollment

Registered

2023-06-13

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Children of age group 5 â?? 15 years fulfilling the diagnostic criteria, irrespective of gender, religion and socioeconomic status

Exclusion criteria

Exclusion criteria: 1.Children of age below 5 years and above 15 years. 2.All other variety of Swasa apart from Tamakaswasa; Swasa an Anubhandha lakshana of any other condition 3. Acute or Severe persistent Asthma which required usage of Nebulisation / inhalation of nasal spray / any other immediate intervention. 4.Diagnosed cases of sever COPD, respiratory distress syndrome (RDS), Pneumonia, Pulmonary TB, and Status Asthmaticus 5.Any other systemic disorder which may interfere with trail

Design outcomes

Primary

Measure	Time frame
Grading Scale of asthama - swasakruchrata,pinasa ,kaphanistevana,ghurghuraka,muhrmuhrswasa,kasa ,kantadwamsaTimepoint: baseline, 30th day ,60th day	—

Secondary

Measure	Time frame
Assessment of Peak exploratory flow rateTimepoint: Assessment will be done on every 15 days of the study	—

Countries

India

Contacts

Public ContactDr Murtujali Makanadar

Rajiv Gandhi University of Health Sciences Bengaluru

drgirishkumargowda@gmail.com9449577136

Outcome results